$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000101473915000017 Filed on November 04, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$243.7M	$247.2M	$244.0M
YoY Change	1.67%	1.34%	27.97%
Cost Of Revenue	$171.1M	$182.0M	$170.7M
YoY Change	0.12%	6.62%	32.34%
Gross Profit	$65.91M	$65.23M	$62.69M
YoY Change	3.5%	4.06%	1.67%
Gross Profit Margin	27.04%	26.39%	25.7%
Selling, General & Admin	$49.30M	$17.90M	$82.20M
YoY Change	-43.79%	-78.22%	46.52%
% of Gross Profit	74.8%	27.44%	131.13%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.200M	$4.029M	$4.205M
YoY Change	205.88%	-4.19%	30.39%
% of Gross Profit	7.89%	6.18%	6.71%
Operating Expenses	$67.80M	$65.60M	$83.70M
YoY Change	-35.55%	-21.62%	47.88%
Operating Profit	-$1.891M	-$19.28M	-$27.71M
YoY Change	-95.45%	-30.4%	3927.18%
Interest Expense	-$9.600M	-$9.500M	$9.563M
YoY Change	3.23%	-199.34%	33.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$15.98M	-$28.79M	-$37.27M
YoY Change	-73.64%	-22.76%	56.82%
Income Tax	$1.000M	-$4.551M	$1.930M
% Of Pretax Income
Net Earnings	-$18.44M	-$16.78M	-$38.71M
YoY Change	-71.01%	-56.64%	13.56%
Net Earnings / Revenue	-7.57%	-6.79%	-15.87%
Basic Earnings Per Share			-$0.57
Diluted Earnings Per Share	-$1.070M	-$976.7K	-$2.250M
COMMON SHARES
Basic Shares Outstanding	68.75M shares	68.73M shares	68.62M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.60M	$29.40M	$0.00
YoY Change	2128.57%
Cash & Equivalents	$15.58M	$29.44M	$0.00
Short-Term Investments
Other Short-Term Assets	$27.80M	$21.90M	$11.10M
YoY Change	48.66%	97.3%	-16.54%
Inventory	$42.98M	$26.89M	$33.78M
Prepaid Expenses
Receivables	$97.40M	$121.2M	$170.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$183.7M	$199.4M	$215.6M
YoY Change	-2.41%	-7.49%	-2.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.94M	$34.11M	$40.05M
YoY Change	-16.33%	-14.84%	-2.44%
Goodwill	$308.7M	$308.7M	$573.3M
YoY Change	-46.15%	-46.15%	-5.34%
Intangibles	$5.128M		$11.88M
YoY Change	-50.06%		-65.15%
Long-Term Investments
YoY Change
Other Assets	$1.161M	$1.158M	$1.275M
YoY Change	-8.73%	-9.18%	-71.58%
Total Long-Term Assets	$347.0M	$363.2M	$643.3M
YoY Change	-45.49%	-43.53%	-8.65%
TOTAL ASSETS
Total Short-Term Assets	$183.7M	$199.4M	$215.6M
Total Long-Term Assets	$347.0M	$363.2M	$643.3M
Total Assets	$530.6M	$562.7M	$858.8M
YoY Change	-35.66%	-34.49%	-7.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.08M	$53.38M	$74.85M
YoY Change	-27.05%	-28.68%	48.86%
Accrued Expenses	$59.80M	$50.40M	$39.90M
YoY Change	11.15%	26.32%	5.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$24.38M	$39.60M	$4.900M
YoY Change	351.9%	708.16%	-86.12%
Total Short-Term Liabilities	$152.8M	$146.8M	$135.5M
YoY Change	-6.42%	8.35%	1.48%
LONG-TERM LIABILITIES
Long-Term Debt	$393.7M	$409.3M	$418.4M
YoY Change	-5.9%	-2.17%	10.02%
Other Long-Term Liabilities	$1.861M	$6.793M	$8.255M
YoY Change	-77.11%	-17.71%	-72.85%
Total Long-Term Liabilities	$1.861M	$6.793M	$8.255M
YoY Change	-77.11%	-17.71%	-72.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$152.8M	$146.8M	$135.5M
Total Long-Term Liabilities	$1.861M	$6.793M	$8.255M
Total Liabilities	$548.6M	$563.0M	$580.3M
YoY Change	-9.76%	-2.98%	4.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$601.9M	-$583.5M	-$238.6M
YoY Change	99.17%	144.56%	75.2%
Common Stock	$531.8M	$533.1M	$527.4M
YoY Change	0.39%	1.07%	2.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.74M	$10.74M	$10.31M
YoY Change	0.54%	4.13%	0.0%
Treasury Stock Shares	2.654M shares	2.654M shares	2.583M shares
Shareholders Equity	-$81.52M	-$61.14M	$278.5M
YoY Change
Total Liabilities & Shareholders Equity	$530.6M	$562.7M	$858.8M
YoY Change	-35.66%	-34.49%	-7.28%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$18.44M	-$16.78M	-$38.71M
YoY Change	-71.01%	-56.64%	13.56%
Depreciation, Depletion And Amortization	$5.200M	$4.029M	$4.205M
YoY Change	205.88%	-4.19%	30.39%
Cash From Operating Activities	$1.900M	-$20.40M	-$700.0K
YoY Change	533.33%	2814.29%	-95.68%
INVESTING ACTIVITIES
Capital Expenditures	-$1.400M	-$4.300M	-$4.400M
YoY Change	-44.0%	-2.27%	-50.56%
Acquisitions
YoY Change
Other Investing Activities	$2.200M	$22.40M	$0.00
YoY Change	144.44%		-100.0%
Cash From Investing Activities	$800.0K	$18.00M	-$4.400M
YoY Change	-150.0%	-509.09%	-98.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.50M	30.70M	3.600M
YoY Change	-885.71%	752.78%	-97.69%
NET CHANGE
Cash From Operating Activities	1.900M	-20.40M	-700.0K
Cash From Investing Activities	800.0K	18.00M	-4.400M
Cash From Financing Activities	-16.50M	30.70M	3.600M
Net Change In Cash	-13.80M	28.30M	-1.500M
YoY Change	-1825.0%	-1986.67%	-98.16%
FREE CASH FLOW
Cash From Operating Activities	$1.900M	-$20.40M	-$700.0K
Capital Expenditures	-$1.400M	-$4.300M	-$4.400M
Free Cash Flow	$3.300M	-$16.10M	$3.700M
YoY Change	17.86%	-535.14%	-150.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	46017000	USD
CY2015Q3	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	48084000	USD
CY2014Q3	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	2922000	USD
	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	14754000	USD
CY2015Q3	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	274000	USD
	bios	Acquisition And Integration Expenses AcquisitionAndIntegrationExpenses	753000	USD
	bios	Adjustmentsto Additional Paidin Capital Accretionof Discounton Temporary Equity AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity	3514000	USD
	bios	Adjustmentsto Additional Paidin Capital Increasein Liquidation Preferenceon Temporary Equity AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity	4162000	USD
	bios	Adjustmentsto Additional Paidin Capital Private Investmentin Public Equity Transaction AdjustmentstoAdditionalPaidinCapitalPrivateInvestmentinPublicEquityTransaction	6583000	USD
CY2014Q4	bios	Allowancefor Doubtful Accounts Percentageof Accounts Receivable AllowanceforDoubtfulAccountsPercentageofAccountsReceivable	0.335
CY2015Q3	bios	Allowancefor Doubtful Accounts Percentageof Accounts Receivable AllowanceforDoubtfulAccountsPercentageofAccountsReceivable	0.366
CY2014Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4869000	USD
CY2015Q3	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3514000	USD
	bios	Classof Warrantor Right Exercise Priceof Warrantsor Rights Percentageof Market Price ClassofWarrantorRightExercisePriceofWarrantsorRightsPercentageofMarketPrice	0.85
	bios	Debt Instrument Debt Default Interest Rate Penalty Increase DebtInstrumentDebtDefaultInterestRatePenaltyIncrease	0.02
CY2014Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	86000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	6941000	USD
CY2015Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	21000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	2139000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	-1354000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	6941000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	21000	USD
CY2014Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	423803000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6687000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4468000	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2014Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	198061000	USD
CY2015Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	191302000	USD
CY2014Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	131656000	USD
CY2015Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	121195000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50643000	USD
CY2015Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	59273000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	529682000	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	533059000	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	56000	USD
CY2015Q3	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	448915000	USD
	bios	Maximum Net Leverage Ratio Is Consistent With Prior Quarters Number MaximumNetLeverageRatioIsConsistentWithPriorQuartersNumber	4	Quarters
CY2014Q3	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	54000	USD
	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	94000	USD
CY2015Q3	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	73000	USD
	bios	Other Interest Income Expense Net OtherInterestIncomeExpenseNet	322000	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	0	USD
	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	59691000	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	62500000	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	59355000	USD
	bios	Registration Rights Agreement Periodof Timebefore Rights Become Effective RegistrationRightsAgreementPeriodofTimebeforeRightsBecomeEffective	P1Y
	bios	Repayments Of Debt Including Accrued Interest RepaymentsOfDebtIncludingAccruedInterest	45300000	USD
CY2015Q3	bios	Restructuringand Related Cost Expected Numberof Positions Eliminated Period Percent RestructuringandRelatedCostExpectedNumberofPositionsEliminatedPeriodPercent	0.12
CY2015Q1	bios	Stock Purchase Agreement Covenant Terms Minimum Percentageof Proceedstobe Usedon Repaymentof Debt StockPurchaseAgreementCovenantTermsMinimumPercentageofProceedstobeUsedonRepaymentofDebt	0.75
	bios	Stock Purchase Agreement Percentageof Proceeds Usedto Repayof Debt StockPurchaseAgreementPercentageofProceedsUsedtoRepayofDebt	0.77
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68747613	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	89203000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	53383000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	66405000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	70107000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	66500000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70107000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	3700000	USD
CY2014Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	132000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	327000	USD
CY2015Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	146000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	428000	USD
CY2014Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	730000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3280000	USD
CY2015Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	740000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2074000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3607000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2929000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1620000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4943000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1286000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4265000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4200000	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6300000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6200000	shares
CY2014Q4	us-gaap	Assets Assets	824713000	USD
CY2015Q3	us-gaap	Assets Assets	562656000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	188215000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	199413000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	9550000	USD
CY2015Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	268000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	11000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	62000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	122000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	73000	USD
CY2014Q3	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	600000	USD
	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1800000	USD
CY2015Q3	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	600000	USD
	us-gaap	Capitalized Computer Software Amortization CapitalizedComputerSoftwareAmortization	1900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1001000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29442000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1001000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	28702000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	57677000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	22375000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	8293000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	4061000	USD
CY2015Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.17
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71274064	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71404664	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68636965	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68747613	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q3	us-gaap	Contractual Obligation ContractualObligation	27425000	USD
CY2015Q3	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	2448000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	2810000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	4798000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	8113000	USD
CY2015Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	6909000	USD
CY2015Q3	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	2347000	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	170692000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	501051000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	184081000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	550255000	USD
CY2014Q3	us-gaap	Cost Of Services CostOfServices	8567000	USD
	us-gaap	Cost Of Services CostOfServices	25528000	USD
CY2015Q3	us-gaap	Cost Of Services CostOfServices	7933000	USD
	us-gaap	Cost Of Services CostOfServices	23397000	USD
CY2014Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	70000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	266000	USD
CY2015Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	19000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	50000	USD
CY2014Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	70000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	266000	USD
CY2015Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	19000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	50000	USD
CY2014Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1653000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	7297000	USD
CY2015Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3803000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-19290000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	13463000	USD
CY2015Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	13244000	USD
CY2014Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1860000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	8218000	USD
CY2015Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4570000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-22594000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.20
CY2014Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	207000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	921000	USD
CY2015Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-767000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3304000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	19058000	USD
CY2015Q3	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	56000	USD
CY2014Q3	us-gaap	Depreciation Depreciation	4205000	USD
	us-gaap	Depreciation Depreciation	11999000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	4029000	USD
	us-gaap	Depreciation Depreciation	12464000	USD
CY2014Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	12744000	USD
CY2015Q3	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.23
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23081000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27345000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33350000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33350000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10269000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6005000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-784000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	560579000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	308729000	USD
CY2014Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2015Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	13850000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	251850000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	60766000	USD
	us-gaap	Gross Profit GrossProfit	181859000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	63143000	USD
	us-gaap	Gross Profit GrossProfit	188223000	USD
CY2014Q3	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	162125000	USD
	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	475523000	USD
CY2015Q3	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	176148000	USD
	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	526858000	USD
CY2014Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	226421000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	667601000	USD
CY2015Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	240846000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	720913000	USD
CY2014Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	5037000	USD
	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	15309000	USD
CY2015Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	6378000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	168000	USD
	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	17565000	USD
CY2014Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	231458000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	682910000	USD
CY2015Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	247224000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	738478000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-39204000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-86585000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24239000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-286436000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-37274000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-78101000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28790000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-308980000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.57
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.27
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.38
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-4.28
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	494000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2743000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	7457000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5172000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.04
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.11
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.08
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1930000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8484000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4551000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22544000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14295000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	33651000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4715000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	42501000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-12464000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-25508000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11275000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-108143000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	54000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	168000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	69000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	168000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	2385000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	43362000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	43000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-446000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-435000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	2000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	5000	USD
CY2015Q3	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	1000	USD
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	3000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1692000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	462000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	12044000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-35822000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-8218000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	21208000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	436000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4586000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-486000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10328000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-553000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-8555000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5924000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3386000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2392000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3623000	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9567000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29203000	USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9507000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-27750000	USD
	us-gaap	Interest Paid Net InterestPaidNet	25328000	USD
	us-gaap	Interest Paid Net InterestPaidNet	23882000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6853000	USD
CY2015Q3	us-gaap	Interest Payable Current InterestPayableCurrent	2268000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	37215000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	26886000	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2000000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5900000	USD
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1800000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5400000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	607908000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	563013000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	824713000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	562656000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	162313000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	146837000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	9976000	USD
CY2015Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2015Q3	us-gaap	Long Term Debt LongTermDebt	418647000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	418408000	USD
CY2015Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	409327000	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	5395000	USD
CY2013Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15000000	USD
CY2014Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-9358000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-31745000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8129000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6793000	USD
CY2015Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	39588000	USD
CY2014Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	56089000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15160000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83098000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	45904000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13017000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-11773000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-67413000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-40038000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-71474000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-38710000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-83842000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-16782000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-281264000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38710000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-83842000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18850000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-288940000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-27707000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-48898000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-19283000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-281230000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	27157000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2810000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4787000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	6847000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7991000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2448000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2274000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1272000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1158000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	166660000	USD
CY2015Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	53601000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	167465000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	11319000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	9358000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2115000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1219000	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	454000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1099000	USD
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9054000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21890000	USD
CY2015Q3	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	24600000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	193851000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3145000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	205700000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	203663000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-59000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-172243000	USD
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1098000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	88814000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	93380000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38171000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34107000	USD
CY2014Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	26082000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	41045000	USD
CY2015Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9321000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	32832000	USD
CY2015Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	12800000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	131656000	USD
CY2015Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	121195000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	248000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	315000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	241203000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	178663000	USD
CY2014Q3	us-gaap	Restructuring Charges RestructuringCharges	1846000	USD
	us-gaap	Restructuring Charges RestructuringCharges	10296000	USD
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges	4043000	USD
	us-gaap	Restructuring Charges RestructuringCharges	12309000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-302206000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-583470000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6637000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3651000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1080077	shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	354583000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	278527000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	216805000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	-61140000	USD
CY2014Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2015Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	169000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3519000	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2015Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	60783000	USD
CY2014Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	USD
CY2015Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1899000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	4157000	USD
CY2014Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	0	USD
CY2015Q3	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	66661629	USD
CY2014Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0
CY2015Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	0	shares
CY2015Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	825000	shares
CY2014Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2015Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	635832	shares
CY2014Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2015Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	635832	shares
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2637099	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2654051	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10679000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	10737000	USD
CY2015Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2900000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68615000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68421000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68742000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68693000	shares

Files In Submission

Name	View Source	Status
0001014739-15-000017-index-headers.html	Edgar Link	pending
0001014739-15-000017-index.html	Edgar Link	pending
0001014739-15-000017.txt	Edgar Link	pending
0001014739-15-000017-xbrl.zip	Edgar Link	pending
bios-20150930.xml	Edgar Link	completed
bios-20150930.xsd	Edgar Link	pending
bios-20150930x10q.htm	Edgar Link	pending
bios-20150930_cal.xml	Edgar Link	unprocessable
bios-20150930_def.xml	Edgar Link	unprocessable
bios-20150930_lab.xml	Edgar Link	unprocessable
bios-20150930_pre.xml	Edgar Link	unprocessable
bios-ex311x2015093010xq.htm	Edgar Link	pending
bios-ex312x2015093010xq.htm	Edgar Link	pending
bios-ex321x2015093010xq.htm	Edgar Link	pending
bios-ex322x2015093010xq.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2015 Q4 Form 10-Q Financial Statement

#000101473915000017 Filed on November 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2015 Q4 Form 10-Q Financial Statement

#000101473915000017 Filed on November 04, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch